Watfa Al-Mamari is a developmental pediatrician who established the first developmental pediatric clinics in Oman in 2011. She has worked closely with academic institutions to ensure that developmental pediatrics is included in the curriculum for both undergraduate and postgraduate students. She has a special interest in autism and led the team to establish a national program in Oman to screen children for autism at 18 months of age.
Al-Mamari graduated from Sultan Qaboos University in Muscat, Oman, and later did her residency and fellowship at McGill University in Montreal, Canada.
Watfa Al-Mamari
Developmental pediatrician
Sultan Qaboos University
From this contributor
How one doctor made Oman a leader on autism in the Middle East
Developmental pediatrician Watfa Al-Mamari is building an autism program in Oman from the ground up.
How one doctor made Oman a leader on autism in the Middle East
By
Laura Dattaro
4 February 2020 | 5 min read
Explore more from The Transmitter
Neurons fuel lung tumors that have spread to brain
Functional synapses between brain cells and cancer cells are key to the metastatic growth, according to new findings from two independent teams.
Neurons fuel lung tumors that have spread to brain
Functional synapses between brain cells and cancer cells are key to the metastatic growth, according to new findings from two independent teams.
By
Sarah DeWeerdt
6 October 2025 | 6 min read
Meet the Autism Data Science Initiative grantees
The awarded projects plan to study gene-and-environment interactions in people, stem cells and organoids, as well as predictors of positive life outcomes in autistic youth and adults.
Meet the Autism Data Science Initiative grantees
The awarded projects plan to study gene-and-environment interactions in people, stem cells and organoids, as well as predictors of positive life outcomes in autistic youth and adults.
By
Calli McMurray
3 October 2025 | 2 min read
Exclusive: The 23 studies the FDA based its expanded leucovorin label on
The studies include 46 people, mostly toddlers, who have cerebral folate deficiency due to variants in a folate transporter.
Exclusive: The 23 studies the FDA based its expanded leucovorin label on
The studies include 46 people, mostly toddlers, who have cerebral folate deficiency due to variants in a folate transporter.
By
Claudia López Lloreda
2 October 2025 | 6 min read